Exact Therapeutics: Difference between revisions

Latest revision as of 20:01, 14 April 2026

About[edit]

Exact Therapeutics AS is a Norwegian biotechnology company developing targeted drug delivery technology for cancer and central nervous system (CNS) diseases. Founded in April 2012, the company has 13 employees and is based at Eitri in Oslo.

Technology Platform[edit]

Exact Therapeutics is developing a proprietary technology platform enabling targeted drug delivery. The platform appears to be applicable across multiple therapeutic areas.

Pipeline[edit]

Pancreatic Cancer[edit]

The company has an active clinical program in pancreatic cancer, one of the most difficult-to-treat cancers with limited treatment options.

CNS[edit]

Programs targeting the central nervous system, including immuno-oncology applications in the brain.

Organization[edit]

The company has a formal governance structure including:

Board of Directors
Management team
Active clinical trials
Financial reports and company presentations
ESG reporting
Active investor relations (EXACT-Tx share)

References[edit]

@@ Line 1: / Line 1: @@
-{{Company
+{{DISPLAYTITLE:Exact Therapeutics}}
-|name=Exact Therapeutics
+{{Infobox company
-|location=Norway
+| name = Exact Therapeutics AS
-|category=AI Drug Discovery & Genomics
+| org_number = 998317487
-|founded=N/A
+| founded = 2012-04-12
-|funding=N/A
+| employees = 13
-|website=N/A
+| address = Norway
+| industry = 72.100 – Biotechnology research
+| website = https://www.exacttherapeutics.com
+| nht_category = Startup
+| description = Exact Therapeutics is a Norwegian biotech company developing a technology platform for targeted drug delivery in oncology (cancer) and CNS diseases. Pipeline includes programs in pancreatic cancer, CNS/immuno-oncology. The company has a board of directors, management team, and active clinical trials. Based on Eitri, Oslo.
+| notes = 13 employees. Active clinical trials. Founded 2012. Pancreatic cancer + CNS pipeline. No disclosed revenue or valuation.
+| related_companies = [[Corticalis]], [[HoloCare]], [[IC Targets]], [[Nordic Brain Tech]], [[Norway Health Tech]]
+| categories = Norway Health Tech, Startups, Biotechnology, Oncology, Drug Delivery
+| sources = https://www.exacttherapeutics.com; https://data.brreg.no/enhetsregisteret/api/enheter/998317487
 }}
-== What They Do ==
+== About ==
-Therapeutics
-== Funding ==
+Exact Therapeutics AS is a Norwegian biotechnology company developing targeted drug delivery technology for cancer and central nervous system (CNS) diseases. Founded in April 2012, the company has 13 employees and is based at Eitri in Oslo.
-'''Valuation:''' Not disclosed. Norway Health Tech member.
-== Revenue ==
+== Technology Platform ==
-'''Source:''' proff.no (to be researched)
-== See Also ==
+Exact Therapeutics is developing a proprietary technology platform enabling targeted drug delivery. The platform appears to be applicable across multiple therapeutic areas.
-* [[Norway Health Tech]]
-* [[Norway]]
-* [[Companies]]
-[[Category:Company]]
+== Pipeline ==
-[[Category:Norway]]
+=== Pancreatic Cancer ===
+The company has an active clinical program in pancreatic cancer, one of the most difficult-to-treat cancers with limited treatment options.
+=== CNS ===
+Programs targeting the central nervous system, including immuno-oncology applications in the brain.
+== Organization ==
+The company has a formal governance structure including:
+* Board of Directors
+* Management team
+* Active clinical trials
+* Financial reports and company presentations
+* ESG reporting
+* Active investor relations (EXACT-Tx share)
+== References ==
+<references/>
+[[Category:Norway Health Tech]]
+[[Category:Startups]]
+[[Category:Biotechnology]]
+[[Category:Oncology]]
+[[Category:Drug Delivery]]